iRADIOLOGY, Volume 2, Issue 1, Page 17-34, February 2024.The composition of a 99mTc‐labeled peptide radiopharmaceutical probe includes the radionuclide (99mTc), chelating agents (6‐hydrazinonicotinic acid, 2 mercaptoacetylglycylglycyl/mercaptoacetyltriglycine, N,N′‐bis(2‐methyl‐2‐mercaptopropyl)ethylenediamine, ethylene dicysteine, N3S, etc.), peptides (peptides targeting tumor receptors such as somatostatin
Jiyun Shi, Shuang Liu
wiley +1 more source
Patologia molecular do receptor de sulfoniluréia (SUR1) [PDF]
, 2000 The sulfonylurea receptor is a subunit of the ATP-sensitive potassium channel, which is expressed in the pancreatic beta cell. The central role of this receptor in glucose-induced insulin secretion was confirmed by description that mutations in this gene
Reis, André Fernandes [UNIFESP] +1 more
core +2 more sources
Anaesthesia for Nesidioblastosisin A New Born: A Case Report
Indian Journal of Anaesthesia, 2008 Congenital hyperinsulinism as seen in nesidioblastosis is the most common cause of non transient neonatal hypoglycaemia. The prime concern in nesidioblastosis is the prevention of dangerous hypoglycaemia which can lead to coma, brain damage or mental ...
K Sunitha Zachariah +3 more
doaj
Glucagon receptor gene mutations with hyperglucagonemia but without the glucagonoma syndrome
, 2015 Pancreatic neoplasms producing exclusively glucagon associated with glucagon cell hyperplasia of the islets and not related to hereditary endocrine syndromes have been recently described.
Cohen, P +8 more
core +1 more source
Nesidioblastosis and Insulinoma: A Rare Coexistence and a Therapeutic Challenge
Frontiers in Endocrinology, 2020 Background: Nesidioblastosis and insulinoma are disorders of the endocrine pancreas causing endogenous hyperinsulinemic hypoglycemia. Their coexistence is very unusual and treatment represents a still unresolved dilemma.Case Description: The patient was ...
Angela Dardano +7 more
doaj +1 more source
A propósito de un caso : paciente con cuadro de disartria de una hora y media de evolución [PDF]
, 2017 Insulinoma is a neoplasia of pancreatic β-cells that secretes insulin. It constitutes a rare cause of hypoglycemia. Poor knowledge of this disease is explained by the low incidence, 4 in 1 million people per year. The nonspecific symptoms and its size
Roldán Vásquez, Ana María
core
A Large Animal Survival Model to Evaluate Bariatric Surgery Mechanisms [PDF]
, 2015 BACKGROUND: The impact of Roux-en-Y gastric bypass (RYGB) on type 2 diabetes mellitus is thought to result from upper and/or lower gut hormone alterations.
Alloosh, Mouhamad +7 more
core +2 more sources
Bariatric surgery and diabetes remission: Sleeve gastrectomy or mini-gastric bypass? [PDF]
, 2013 AIM: To investigate the weight loss and glycemic control status [blood glucose, hemoglobin A1c (HbA1c) and hypoglycaemic treatment]. METHODS: The primary risk factor for type 2 diabetes is obesity, and 90% of all patients with type 2 diabetes are ...
Bianco P +10 more
core +1 more source
Persistent hyperinsulinemic hypoglycemia of infancy: An overview of current concepts
Journal of Indian Association of Pediatric Surgeons, 2012 Persistent hyperinsulinemic hypoglycemia of infancy (PHHI) is relatively rare but one of the most important causes of severe neonatal hypoglycemia.
Prabudh Goel, Subhasis Roy Choudhury
doaj +1 more source
Glucagon-like peptide-1 (GLP-1) receptors are not overexpressed in pancreatic islets from patients with severe hyperinsulinaemic hypoglycaemia following gastric bypass [PDF]
, 2018 Aims/hypothesis: Glucagon-like peptide-1 (GLP-1) receptors are highly overexpressed in benign insulinomas, permitting in vivo tumour visualisation with GLP-1 receptor scanning.
Callery, M. +7 more
core